Connect with us
Able has designed a robotic exoskeleton for people with disabilities. In Germany, Able's CEO highlights the fact that the company has carried out part of the...
Moderna is now advancing two bivalent candidates for fall, based on differing market preferences for Omicron subvariants. The bivalent booster mRNA-1273.214 is the only candidate that...
With the capital raised, Nimble will complete the preclinical testing phase, incorporate regulation and hire personnel. In addition, the company intends to test its tool within...
Delta Med is also active in the production and distribution in Italy and abroad of medical devices and disposable accessories for infusion therapies, procedural kits for...
PBEs have doubled the number of clinical trials in the last five years, and their success rates are higher than those of their 'big sisters', according...
Moderna's commitment to Spain was made clear last Tuesday, June 7th, when representatives of the US biotech company met with the President of the Government, Pedro...
VB Devices closed 2021 with sales of $339,000 (€315,000), the target for 2022 is to achieve $977,000 (€909,000) and for 2023 to exceed $1.6 million (€1.5...
Minoryx Therapeutics, based in Mataró (Barcelona), will also finance the activities necessary to be able to proceed with the approval of leriglitazone in the United States...
Immuno-oncology and molecular oncology are two of Sanofi's most promising bets to tackle some of the most difficult-to-treat cancers. While immuno-oncology research is focused on finding...
Rovi's increase was mainly driven by the strength of the third-party manufacturing business, which grew by 167%. Farma posted a net profit of $28 million (€26.6...